COVID Vaccine Developer Announcements

Featured Journal Content

 

COVID Vaccine Developer Announcements

Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
Feb 19, 2021

Dr. Reddy’s Initiates Process for Emergency Use Authorization of Sputnik V
February 19, 2021
Dr. Reddy’s Laboratories Ltd today announced that it has initiated the process with the Drugs Controller General of India (DCGI) for Emergency Use Authorization (EUA) of the well-studied human adenoviral vector-based platform vaccine candidate, Sputnik V…
As part of the review process, Dr. Reddy’s will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 21st February 2021.
In September 2020, Dr. Reddy’s partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of the Sputnik V and for its distribution rights in India. The vaccine is currently undergoing the phase 3 clinical trial in India…
Ethics Approval Granted for Open Orphan’s COVID-19 Human Challenge Study Model
Call for volunteers to enroll in studies that will play a key part in developing effective vaccines and treatments for COVID-19
February 17, 2021

European Commission Purchases Additional 150 Million Doses of COVID-19 Vaccine Moderna
February 17, 2021